KG
FLGT icon

Kilter Group’s Fulgent Genetics FLGT Stock Holding History

Kilter Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24K Buy
+109
New +$1.85K ﹤0.01% 982
2026
Q1 		– Sell
-4
Closed -$106 – 1620
2025
Q4 		$106 Buy
+4
New +$104 ﹤0.01% 1346

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kilter Group's FLGT Position: Q2 2026 in Review

Kilter Group opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 109 shares worth $2.24K. The stake represents ﹤0.01% of the portfolio and ranks #982 among its holdings. This is a return to the name: Kilter Group previously reported a position in FLGT as recently as Q4 2025.

Kilter Group first reported a position in FLGT in Q4 2025 and has held it in 2 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Kilter Group held 109 shares of Fulgent Genetics worth $2.24K as of Q2 2026.
  • Fulgent Genetics was a new Kilter Group position in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #982 holding.
  • Kilter Group first reported a position in Fulgent Genetics in Q4 2025 and has held it in 2 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.